The distinct bio-PA chemistry systems and their feedstocks
Bio-based polyamides are engineering thermoplastics in which one or more monomers — diamines, diacids, or amino acids — are sourced from renewable biological feedstocks such as castor oil, fatty acids, sugars, and lignocellulosic biomass rather than from petroleum. The core technical challenge is deriving bifunctional nitrogen-containing monomers from these renewable sources and polymerizing them into high-performance amide-linked chains via melt polycondensation or enzymatic routes.
Six chemically distinct bio-PA systems are documented in the patent and literature evidence. Polyamide 11 (PA 11), derived from 11-aminoundecanoic acid sourced from castor oil, is the earliest mass-produced bio-based polyamide — commercially established as a fiber and film material. Polyamide 10,10 (PA 1010), synthesized from sebacic acid and 1,10-decanediamine (both castor-oil derived), is documented in blend formulations with bio-PET for engineering applications. Polyamide 12,36 (PA 12,36), a thermoplastic polyamide elastomer (TPAE) synthesized from 1,12-dodecanediamine and fatty dimer acid, is described with microcellular foaming via supercritical CO₂.
Moving beyond castor oil, furan-based bio-PA synthesized from dimethyl furan-2,5-dicarboxylate — a lignocellulose-derived monomer — and 1,3-cyclohexanedimethanamine represents a next-generation amorphous polyamide route. BDIS-class bio-PAs, built from bio-based 1,4-butanediamine, 1,10-decanediamine, itaconic acid, and sebacic acid, are studied as elastomeric matrices with water-responsive behavior. Finally, poly(ether-block-amide) (PEBA / Pebax®Rnew®) block copolymers — in which the polyamide hard block derives from castor beans — have been validated for additive manufacturing.
Enzymatic synthesis routes use biological catalysts rather than thermal polycondensation to form amide bonds, enabling polyamide formation under mild conditions without chemical catalysts. The University of Groningen formally reviewed this approach in 2016, establishing the methodological groundwork for greener bio-PA production pathways.
Two decades of development: how the bio-PA field matured
The bio-based polyamide field exhibits a clear three-phase trajectory spanning approximately two decades, visible in the publication and filing dates across the patent and literature dataset. Each phase marks a distinct shift in the type of activity — from foundational chemistry to diversified synthesis, and most recently to engineering-scale application.
Early/Foundational Phase (pre-2010): Foundational work on bio-compatible polymer architectures appears as early as 2002–2006, with biodegradable polymer compositions from The General Hospital Corp. and Nippon Shokubai. PA 11’s commercial origin via the castor oil route predates this dataset entirely, establishing it as the earliest mass-produced bio-PA.
Development/Diversification Phase (2013–2019): Academic output accelerated significantly during this period. Key publications include the 2016 synthesis of BDIS polyamide elastomers using green plasticizers (Beijing University of Chemical Technology), the 2016 bioPET/bioPA 1010 blend characterization (Universitat Politècnica de València), and the 2019 PA 11/PBS binary blend study (CNR Italy). Enzymatic synthesis of bio-based polyesters and polyamides was also reviewed formally in 2016 (University of Groningen), establishing the methodological groundwork for greener production pathways. According to WIPO, bio-based polymer patent filings have grown steadily across this period as sustainability mandates tightened globally.
“The most recent filings and publications (2022–2025) signal a transition from lab synthesis to engineering applications — with Korean OEM suppliers filing IP around bio-PA tire reinforcement with explicit recyclability requirements.”
Acceleration/Application Phase (2020–2025): The most recent filings and publications signal transition from lab synthesis to engineering applications. Key markers include the 2022 study on Pebax®Rnew® in fused filament fabrication (FHNW Switzerland), the 2024 synthesis of PA 12,36 microcellular foams (National Taipei University of Technology), the 2022 filing of a biomass-based polyamide tire cord patent (Hankook Tire & Technology Co., Ltd.), and the 2023 filing for a recyclable bio-PA multifilament fiber for tire cords (Hyosung Advanced Materials Corporation). A 2025-dated active Japanese patent (Toyobo MC Co., Ltd.) on a biomass-derived polyester elastomer resin composition signals continued active prosecution in Asia.
The bio-based polyamide field has followed a three-phase trajectory: a foundational phase (pre-2010) based on castor oil chemistry, a diversification phase (2013–2019) driven by academic synthesis research, and an acceleration phase (2020–2025) marked by industrial patent filings from Korean automotive suppliers and Japanese materials companies.
Track bio-PA patent families and filing trends across jurisdictions in real time.
Explore Bio-PA Patents in PatSnap Eureka →Where bio-based polyamides are finding commercial traction
Bio-based polyamides are documented across five distinct application domains in the patent and literature evidence, ranging from high-volume automotive reinforcement to differentiated additive manufacturing niches. The breadth of application is a signal of bio-PA’s versatility — but the depth of IP protection varies significantly by domain.
Tire and Automotive Cord Reinforcement
This is the most commercially concrete application cluster in the dataset. Two Korean patents explicitly address bio-PA for tire cord applications. Hankook Tire & Technology Co., Ltd. filed in 2022 covering biomass-based PA (or PET) as carcass ply or cap ply cord material. Hyosung Advanced Materials Corporation filed in 2023 specifying a bio-PA multifilament with copper stabilizer at 30–300 ppm, sulfuric acid relative viscosity of 2.5–5, and a target tensile strength of ≥8 g/d — all engineering-grade specifications indicating readiness for production-scale qualification. Regulatory bodies including the EPA and the EU are tightening lifecycle emissions standards for vehicle components, accelerating OEM interest in bio-content materials across the supply chain.
The Hyosung Advanced Materials Corporation 2023 patent specifies a recyclable bio-PA multifilament for tire cord applications with a copper stabilizer concentration of 30–300 ppm, sulfuric acid relative viscosity of 2.5–5, and tensile strength target of ≥8 g/d — combining bio-content with explicit recyclability requirements.
Additive Manufacturing
The Pebax®Rnew® PEBA system, with castor-bean-derived PA blocks, has been validated for fused filament fabrication (FFF) by FHNW University of Applied Sciences and Arts (Switzerland, 2022). This demonstrates suitability for flexible, high-performance printed structures and offers a market entry path for bio-PA in 3D printing that bypasses the need to displace commodity nylon at scale — a lower-risk, higher-margin beachhead for new entrants. Standards bodies such as ISO are actively developing additive manufacturing material qualification frameworks that bio-PA suppliers will need to navigate.
Functional Foams
Supercritical CO₂ foaming of PA 12,36 thermoplastic elastomers yields microcellular foams with high elongation at break of 1378% and low density — relevant to footwear, cushioning, and vibration-damping applications. This positions bio-PAs as viable candidates for lightweight foam applications currently dominated by petroleum-based TPU and EVA.
Textiles and Specialty Fibers
Melt-spun bio-PA fibers are documented for functional textile applications, including luminescent composite fibers from BDIS/Eu(TTA)₃Phen systems demonstrated by Beijing Institute of Fashion Technology (2018). PA 11 is also established as a fiber and film material in the broader bioplastics literature. These applications benefit from the inherent flexibility and chemical resistance of long-chain bio-PAs.
Engineering Plastics and Blends
Blending bio-PA with bio-PET or PBS to create toughened, high-renewable-content engineering compounds is documented for injection-moulded parts in automotive, consumer, and industrial settings. The 2019 bioPET/bioPA 1010 blend study (Universitat Politècnica de València) used a glycidyl methacrylate-based compatibilizer to improve interfacial adhesion, while the CNR Italy PA 11/PBS blend study (2019) characterized morphological and thermal properties of the binary system.
Geographic and assignee footprint: who is filing and where
Korea emerges as the most active jurisdiction for applied bio-PA patent filings in this dataset, with two directly relevant active or recently filed patents from Hankook Tire & Technology Co., Ltd. (2022) and Hyosung Advanced Materials Corporation (2023) — both targeting tire cord applications. Japan is represented by active filings including biomass-derived polyester elastomers from Toyobo MC Co., Ltd. (2025) and bio-polyurethane resins from Dainichiseika Color & Chemicals Mfg. Co., Ltd., signaling continued Asian industrial engagement.
China leads academic bio-based polyamide synthesis research in this dataset, with significant contributions from Beijing University of Chemical Technology, Beijing Institute of Fashion Technology, and Donghua University — collectively the most concentrated academic bio-PA research cluster — yet this academic output has not yet been matched by Chinese patent filings in the dataset.
Academic and research output is geographically diverse. China represents the most concentrated academic bio-PA research cluster in this dataset, with Beijing University of Chemical Technology, Beijing Institute of Fashion Technology, and Donghua University collectively covering BDIS elastomers, FDCA-route amorphous PAs, and functional fiber applications. European institutions — CNR Italy, Universitat Politècnica de València (Spain), University of Groningen (Netherlands), and FHNW Switzerland — contribute primarily through blend science, enzymatic routes, and additive manufacturing. Taiwan’s National Taipei University of Technology has produced advanced TPAE and microcellular foam synthesis work. As tracked by the EPO, bio-based polymer patent applications in Europe have been rising as the EU’s circular economy action plan creates regulatory pull for renewable content materials.
The volume of Chinese institutional research on BDIS and FDCA polyamides suggests a pipeline of potential commercial applications. However, this academic output has not yet been matched by Chinese patent filings in this dataset — monitoring CNIPA filings in these sub-classes is warranted for IP strategists tracking freedom-to-operate risk.
No single large chemical conglomerate (such as Arkema, EMS-Chemie, or BASF) appears directly in this dataset’s patent records for bio-PA, though Arkema’s Pebax®Rnew® is cited in the academic literature. This creates a competitive landscape in which tier-one automotive suppliers and specialty fiber producers are the primary IP holders, with major chemical players occupying a referenced — but not directly filing — position in the evidence base.
Map the full bio-PA assignee landscape and monitor CNIPA filings with PatSnap Eureka.
Analyse Bio-PA Patents in PatSnap Eureka →Emerging directions and the next competitive frontier
The most recent filings and publications (2022–2025) in this dataset point to five distinct emerging directions for bio-based polyamide technology, each carrying specific implications for R&D investment and IP strategy.
1. Tire Cord Electrification and Circular Economy Integration
Two Korean patents filed in 2022–2023 by Hankook and Hyosung specifically target bio-PA as a structural reinforcement for tires. This is a high-volume, performance-demanding application that, if scaled, would represent a step-change in bio-PA consumption. The Hyosung 2023 filing specifies recyclability alongside bio-content — signaling circular economy integration as a co-requirement alongside renewable sourcing. R&D teams targeting automotive applications should prioritize PA 6 or PA 66 bio-drop-in equivalents with mechanical parity and track these filing families for freedom-to-operate analysis.
2. Microcellular and Supercritical CO₂ Foam Processing
The PA 12,36 microcellular foam study (National Taipei University of Technology, 2024) demonstrates that fatty dimer acid-based bio-TPAEs are processable via supercritical CO₂ foaming, with competitive cell morphology and outstanding elasticity (elongation at break: 1378%). This positions bio-PAs as viable candidates for lightweight cushioning and footwear foam applications currently dominated by petroleum-based TPU and EVA.
3. FDCA-Route Amorphous Bio-PA with High Glass-Transition Temperature
The synthesis of bio-PA from dimethyl furan-2,5-dicarboxylate and 1,3-cyclohexanedimethanamine (Donghua University, 2021) establishes a new design space: amorphous bio-PAs with glass-transition temperatures of 150–180°C. While molecular weight limitations from steric effects need to be resolved, this represents a potential bio-based entry into optical, barrier, and high-temperature engineering grades — a segment currently served only by petroleum-derived amorphous nylons.
4. Industrial-Grade Processing Standardization
A 2025 Japanese active patent (Toyobo MC Co., Ltd.) targeting biomass-derived polyester elastomer resin compositions with controlled oligomer content (≤2.5 wt%) and melt tension specifications signals industrial-grade processing standardization — a prerequisite for bio-based materials entering demanding extrusion and molding applications. This type of specification-driven filing marks a maturation from proof-of-concept to production-ready formulation.
5. Enzymatic and Solvent-Free Bio-PA Synthesis
Enzymatic polymerization reviewed by the University of Groningen (2016) and the chemoenzymatic synthesis of poly(alanine-nylon-alanine) (Japan, 2020) point toward a longer-term trajectory of low-energy, catalyst-free bio-PA synthesis routes compatible with circular economy principles. These approaches remain at the research stage but are consistent with the direction of green chemistry policy as articulated by bodies such as the OECD in its sustainable chemistry frameworks.
“Castor oil supply chain concentration is a structural risk: the dominant commercial bio-PAs — PA 11, PA 10,10, and PEBA — all trace back to castor oil. Diversification toward lignocellulosic FDCA-route PAs or fermentation-derived diamines is not yet at commercial scale.”
Across all five directions, a consistent theme emerges: recyclability is becoming a co-requirement alongside bio-content. The Hyosung 2023 patent explicitly combines bio-based sourcing with recyclability. Product developers should design for end-of-life from the outset — bio-PA grades that cannot demonstrate chemical recyclability will face increasing regulatory and procurement headwinds in the EU and Korean markets. The PatSnap IP intelligence platform and PatSnap R&D solutions provide the tools to monitor these filing families and assess freedom-to-operate as the landscape evolves.